Unnati Pharmax

Harvoni (Ledifos) Tablets
Composition: Sofosbuvir 400 mg + Ledipasvir 90 mg
International Trade Name: Harvoni®

Harvoni (Ledifos) Tablets is a high-quality fixed-dose combination of Sofosbuvir 400 mg and Ledipasvir 90 mg, a trusted antiviral therapy equivalent to the internationally recognized brand Harvoni®. Manufactured in WHO-GMP certified facilities, Harvoni (Ledifos) Tablets are supplied by reputable pharmaceutical exporters from India, supporting advanced global antiviral treatment programs, particularly for chronic hepatitis C virus (HCV) infection.

This combination therapy acts by inhibiting key viral enzymes: Sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase, and Ledipasvir is an NS5A inhibitor, together effectively suppressing viral replication and promoting sustained virologic response. Harvoni (Ledifos) Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis C infection (genotype 1), including those with compensated liver disease and certain treatment-experienced patients.

Keywords: Sofosbuvir 400 mg + Ledipasvir 90 mg tablet, Harvoni biosimilar, Ledifos tablet, chronic hepatitis C treatment, antiviral therapy, HCV management, fixed-dose combination, pharmaceutical exporter India, antiviral tablet manufacturer India.

Harvoni (Ledifos) Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Tenvir 300 mg Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Viread®

Tenvir 300 mg Tablets is a high-quality Tenofovir Disoproxil Fumarate (TDF) 300 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Viread®. Manufactured in WHO-GMP certified facilities, Tenvir Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV and chronic hepatitis B virus (HBV) treatment programs.

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI) that effectively suppresses viral replication in HIV-1 and HBV infections, helping maintain immune function and preventing disease progression. Tenvir 300 mg Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection and chronic hepatitis B infection.

Keywords: Tenofovir Disoproxil Fumarate 300 mg tablet, Tenvir tablet, Viread biosimilar, antiviral therapy, HIV treatment, chronic hepatitis B management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Tenvir 300 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tafero EM Tablet
Composition: Emtricitabine 200mg + Tenofovir Alafenamide 25mg
International Trade Name: Truvada®

Tafero EM Tablet is a high-quality fixed-dose antiretroviral formulation combining Emtricitabine and Tenofovir Alafenamide, a modern generic equivalent of the internationally recognized Truvada®. Manufactured in WHO-GMP certified facilities, Tafero EM is supplied by trusted pharmaceutical exporters from India to support global HIV prevention and treatment programs, including both therapeutic and prophylactic use.

Emtricitabine, a nucleoside reverse transcriptase inhibitor (NRTI), together with Tenofovir Alafenamide, a novel nucleotide reverse transcriptase inhibitor with improved renal and bone safety profile, provides potent and sustained inhibition of HIV-1 replication. Tafero EM Tablet is primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents and is also widely used for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV acquisition in high-risk populations.

Emtricitabine + Tenofovir Alafenamide tablets, Tafero EM tablet, Truvada TAF generic, PrEP HIV medicine, HIV-1 treatment tablets, antiretroviral exporter India, and HIV pharmaceutical manufacturer India.

Tafero EM Tablet is manufactured under stringent GMP and international pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for ART centers, HIV clinics, government prevention programs, international NGOs, and global pharmaceutical distributors.

Spegra Tablet
Composition: Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg
International Trade Name: Odefsey®

Spegra Tablet is a premium fixed-dose combination of Dolutegravir, Emtricitabine, and Tenofovir Alafenamide, serving as a high-quality generic equivalent of the internationally recognized Odefsey®. Manufactured in WHO-GMP certified facilities, Spegra is supplied by trusted pharmaceutical exporters from India to support advanced global HIV treatment programs.

This combination therapy includes Dolutegravir, an integrase strand transfer inhibitor (INSTI), Emtricitabine, a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Alafenamide (TAF), a nucleotide reverse transcriptase inhibitor. Together, they provide potent, once-daily suppression of HIV-1 replication, improved immune function, and a convenient single-tablet regimen for adult patients living with HIV.

Dolutegravir + Emtricitabine + Tenofovir Alafenamide tablets, Spegra tablets, Odefsey generic, HIV-1 antiretroviral therapy, fixed-dose combination ARV, Indian pharmaceutical exporter, HIV treatment provider India.

Spegra Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government HIV programs, and international pharmaceutical distributors.

Valcivir Tablet
Composition: Valacyclovir 1000mg
International Trade Name: Valtrex®

Valcivir Tablet is a high-quality antiviral medication containing Valacyclovir 1000mg, a generic equivalent of the internationally recognized Valtrex®. Manufactured in WHO-GMP certified facilities, Valcivir is supplied by trusted pharmaceutical exporters from India to support global treatment programs for herpes virus infections.

Valacyclovir is a prodrug of acyclovir that inhibits viral DNA polymerase, effectively preventing replication of herpes simplex virus (HSV) and varicella-zoster virus (VZV). Valcivir 1000mg Tablet is primarily indicated for the treatment of herpes zoster (shingles), genital herpes, and recurrent cold sores, helping reduce symptom severity, speed recovery, and prevent viral transmission.

Valacyclovir 1000mg tablet, Valcivir tablet, Valtrex generic, HSV antiviral therapy, shingles treatment, oral antiviral medication, Indian pharmaceutical exporter, antiviral supplier India.

Valcivir Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government health programs, and international pharmaceutical distributors.

Herpival 1G Tablets
Composition: Valacyclovir Hydrochloride Tablets USP 1g
International Trade Name: Valtrex®

Herpival 1G is a high-quality Valacyclovir Hydrochloride 1g tablet, a trusted antiviral medication equivalent to the internationally recognized brand Valtrex®. Manufactured in WHO-GMP certified facilities, Herpival Tablets are supplied by reliable pharmaceutical exporters from India, supporting advanced global antiviral treatment programs, particularly for herpes virus infections.

Valacyclovir Hydrochloride is a prodrug of acyclovir, which inhibits viral DNA replication, providing effective management of herpes simplex virus (HSV) infections, herpes zoster (shingles), and varicella (chickenpox). Herpival 1G Tablets are primarily indicated for the treatment of adult patients with HSV infections, including genital herpes, cold sores, and for the prevention of recurrent outbreaks.

Keywords: Valacyclovir 1g tablet, Herpival tablets, Valtrex biosimilar, antiviral therapy, HSV treatment, herpes zoster treatment, acyclovir prodrug, oral antiviral tablets, pharmaceutical exporter India, antiviral medication manufacturer India.

Herpival 1G Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

HERPIVAL 500 Tablets
Composition: Valacyclovir Hydrochloride 500 mg
International Trade Name: Valtrex®

HERPIVAL 500 is a high-quality Valacyclovir Hydrochloride 500 mg oral tablet, a biosimilar equivalent of the internationally recognized antiviral therapy marketed under the brand name Valtrex®. Manufactured in WHO-GMP certified facilities, HERPIVAL Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global treatment programs for herpes simplex virus (HSV) infections and varicella-zoster virus (VZV) infections.

Valacyclovir is a prodrug of acyclovir that inhibits viral DNA polymerase, effectively suppressing viral replication and reducing the severity and duration of herpes infections. HERPIVAL 500 Tablets are primarily indicated for the treatment of herpes zoster (shingles), genital herpes, and for the management of cold sores (herpes labialis).

Valacyclovir 500 mg tablet, HERPIVAL 500 tablet, Valtrex biosimilar, herpes treatment, antiviral therapy, HSV and VZV management, pharmaceutical exporter India, and antiviral tablet manufacturer India.

HERPIVAL 500 Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Entavir 1mg Tablet
Composition: Entecavir 1mg
International Trade Name: Baraclude®

Entavir 1mg is a high-quality Entecavir 1mg tablet, a potent antiviral medication widely recognized under the international brand Baraclude®. Manufactured in WHO-GMP certified facilities, Entavir is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a nucleoside analogue that inhibits hepatitis B virus replication, helping to reduce viral load and prevent disease progression. Entavir 1mg Tablet is primarily indicated for the treatment of chronic hepatitis B infection in adult patients with active viral replication and evidence of liver inflammation or fibrosis.

Entecavir 1mg tablets, Entavir tablets, Baraclude generic, HBV antiviral therapy, chronic hepatitis B management, nucleoside analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Entavir 1mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

X VIR 0.5 mg Tablets
Composition: Entecavir Tablets 0.5 mg
International Trade Name: Baraclude®

X VIR 0.5 mg Tablets is a high-quality Entecavir 0.5 mg oral tablet, a trusted antiviral medication equivalent to the internationally recognized brand Baraclude®. Manufactured in WHO-GMP certified facilities, X VIR Tablets are supplied by reputable pharmaceutical exporters from India, supporting advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a potent nucleoside analogue that inhibits HBV DNA polymerase, effectively suppressing viral replication and reducing liver inflammation. X VIR 0.5 mg Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis B infection, including those with compensated or decompensated liver disease, to prevent disease progression and improve liver function.

Keywords: Entecavir 0.5 mg tablet, X VIR tablet, Baraclude biosimilar, chronic hepatitis B treatment, antiviral therapy, HBV infection management, nucleoside analogue, pharmaceutical exporter India, antiviral tablet manufacturer India.

X VIR 0.5 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Entehep 0.5mg Tablet
Composition: Entecavir 0.5mg
International Trade Name: Baraclude®

Entehep 0.5mg is a high-quality Entecavir 0.5mg tablet, a potent antiviral medication and generic equivalent of the internationally recognized Baraclude®. Manufactured in WHO-GMP certified facilities, Entehep is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a nucleoside analogue that effectively inhibits hepatitis B virus replication, reducing viral load and preventing liver disease progression. Entehep 0.5mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with evidence of active viral replication and liver inflammation.

Entecavir 0.5mg tablets, Entehep tablets, Baraclude generic, HBV antiviral therapy, chronic hepatitis B management, nucleoside analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Entehep 0.5mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

ENTEHEP 1 mg Tablets
Composition: Entecavir Tablets 1 mg
International Trade Name: Baraclude®

ENTEHEP 1 mg Tablets is a high-quality Entecavir 1 mg oral tablet, a trusted antiviral medication equivalent to the internationally recognized brand Baraclude®. Manufactured in WHO-GMP certified facilities, ENTEHEP Tablets are supplied by reliable pharmaceutical exporters from India, supporting advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a potent nucleoside analogue that inhibits HBV DNA polymerase, effectively suppressing viral replication, reducing liver inflammation, and preventing disease progression. ENTEHEP 1 mg Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis B infection, including those with compensated or decompensated liver disease.

Keywords: Entecavir 1 mg tablet, ENTEHEP tablet, Baraclude biosimilar, chronic hepatitis B treatment, antiviral therapy, HBV infection management, nucleoside analogue, pharmaceutical exporter India, antiviral tablet manufacturer India.

ENTEHEP 1 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Entaliv 0.5mg Tablet
Composition: Entecavir 0.5mg
International Trade Name: Baraclude®

Entaliv 0.5mg is a premium-quality Entecavir 0.5mg tablet, a potent antiviral medication and generic equivalent of the internationally recognized Baraclude®. Manufactured in WHO-GMP certified facilities, Entaliv is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a nucleoside analogue that effectively inhibits HBV replication, helping reduce viral load and prevent liver disease progression. Entaliv 0.5mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with active viral replication and liver inflammation or fibrosis.

Entecavir 0.5mg tablets, Entaliv tablets, Baraclude generic, HBV antiviral therapy, chronic hepatitis B management, nucleoside analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Entaliv 0.5mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

X VIR 1 mg Tablets
Composition: Entecavir Tablets 1 mg
International Trade Name: Baraclude®

X VIR 1 mg Tablets is a high-quality Entecavir 1 mg oral tablet, a trusted antiviral medication equivalent to the internationally recognized brand Baraclude®. Manufactured in WHO-GMP certified facilities, X VIR Tablets are supplied by reputable pharmaceutical exporters from India, supporting advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a potent nucleoside analogue that inhibits HBV DNA polymerase, effectively suppressing viral replication, reducing liver inflammation, and preventing disease progression. X VIR 1 mg Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis B infection, including those with compensated or decompensated liver disease.

Keywords: Entecavir 1 mg tablet, X VIR tablet, Baraclude biosimilar, chronic hepatitis B treatment, antiviral therapy, HBV infection management, nucleoside analogue, pharmaceutical exporter India, antiviral tablet manufacturer India.

X VIR 1 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Cronivir 0.5 mg Tablets
Composition: Entecavir Tablets 0.5 mg
International Trade Name: Baraclude®

Cronivir 0.5 mg Tablets is a high-quality Entecavir 0.5 mg oral tablet, a trusted antiviral medication equivalent to the internationally recognized brand Baraclude®. Manufactured in WHO-GMP certified facilities, Cronivir Tablets are supplied by reliable pharmaceutical exporters from India, supporting advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a potent nucleoside analogue that inhibits HBV DNA polymerase, effectively suppressing viral replication, reducing liver inflammation, and preventing disease progression. Cronivir 0.5 mg Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis B infection, including those with compensated or decompensated liver disease.

Keywords: Entecavir 0.5 mg tablet, Cronivir tablet, Baraclude biosimilar, chronic hepatitis B treatment, antiviral therapy, HBV infection management, nucleoside analogue, pharmaceutical exporter India, antiviral tablet manufacturer India.

Cronivir 0.5 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Entekor 0.5mg Tablet
Composition: Entecavir 0.5mg
International Trade Name: Baraclude®

Entekor 0.5mg is a high-quality Entecavir 0.5mg tablet, a potent antiviral medication and generic equivalent of the internationally recognized Baraclude®. Manufactured in WHO-GMP certified facilities, Entekor is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a nucleoside analogue that effectively inhibits HBV replication, helping reduce viral load and prevent liver disease progression. Entekor 0.5mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with active viral replication and liver inflammation or fibrosis.

Entecavir 0.5mg tablets, Entekor tablets, Baraclude generic, HBV antiviral therapy, chronic hepatitis B management, nucleoside analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Entekor 0.5mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

ENTEKOR 1 mg Tablets
Composition: Entecavir Tablets 1 mg
International Trade Name: Baraclude®

ENTEKOR 1 mg Tablets is a high-quality Entecavir 1 mg oral tablet, a trusted antiviral medication equivalent to the internationally recognized brand Baraclude®. Manufactured in WHO-GMP certified facilities, ENTEKOR Tablets are supplied by reliable pharmaceutical exporters from India, supporting advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a potent nucleoside analogue that inhibits HBV DNA polymerase, effectively suppressing viral replication, reducing liver inflammation, and preventing disease progression. ENTEKOR 1 mg Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis B infection, including those with compensated or decompensated liver disease.

Keywords: Entecavir 1 mg tablet, ENTEKOR tablet, Baraclude biosimilar, chronic hepatitis B treatment, antiviral therapy, HBV infection management, nucleoside analogue, pharmaceutical exporter India, antiviral tablet manufacturer India.

ENTEKOR 1 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Entavir 0.5mg Tablet
Composition: Entecavir 0.5mg
International Trade Name: Baraclude®

Entavir 0.5mg is a high-quality Entecavir 0.5mg tablet, a potent antiviral medication and generic equivalent of the internationally recognized Baraclude®. Manufactured in WHO-GMP certified facilities, Entavir is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a nucleoside analogue that effectively inhibits HBV replication, helping reduce viral load and prevent liver disease progression. Entavir 0.5mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with active viral replication and liver inflammation or fibrosis.

Entecavir 0.5mg tablets, Entavir tablets, Baraclude generic, HBV antiviral therapy, chronic hepatitis B management, nucleoside analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Entavir 0.5mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Samhep-E 0.5mg Tablet
Composition: Entecavir 0.5mg
International Trade Name: Baraclude®

Samhep-E 0.5mg is a high-quality Entecavir 0.5mg tablet, a potent antiviral medication and generic equivalent of the internationally recognized Baraclude®. Manufactured in WHO-GMP certified facilities, Samhep-E is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a nucleoside analogue that effectively inhibits HBV replication, helping reduce viral load and prevent liver disease progression. Samhep-E 0.5mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with active viral replication and liver inflammation or fibrosis.

Entecavir 0.5mg tablets, Samhep-E tablets, Baraclude generic, HBV antiviral therapy, chronic hepatitis B management, nucleoside analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Samhep-E 0.5mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Hepalo 0.5mg Tablet
Composition: Entecavir 0.5mg
International Trade Name: Baraclude®

Hepalo 0.5mg is a high-quality Entecavir 0.5mg tablet, a potent antiviral medication and generic equivalent of the internationally recognized Baraclude®. Manufactured in WHO-GMP certified facilities, Hepalo is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Entecavir is a nucleoside analogue that effectively inhibits HBV replication, helping reduce viral load and prevent liver disease progression. Hepalo 0.5mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with active viral replication and liver inflammation or fibrosis.

Entecavir 0.5mg tablets, Hepalo tablets, Baraclude generic, HBV antiviral therapy, chronic hepatitis B management, nucleoside analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Hepalo 0.5mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Entecashiv 0.5 mg Tablets
Composition: Entecavir 0.5 mg
International Trade Name: Baraclude®

Entecashiv 0.5 mg Tablets is a high-quality Entecavir 0.5 mg oral tablet, a biosimilar equivalent of the internationally recognized antiviral agent marketed under the brand name Baraclude®. Manufactured in WHO-GMP certified facilities, Entecashiv Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly in chronic hepatitis B virus (HBV) infection.

Entecavir is a potent nucleoside analogue that inhibits HBV DNA polymerase, effectively suppressing viral replication, reducing liver inflammation, and preventing disease progression. Entecashiv 0.5 mg Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis B infection, including those with compensated or decompensated liver disease.

Keywords: Entecavir 0.5 mg tablet, Entecashiv tablet, Baraclude biosimilar, chronic hepatitis B treatment, antiviral therapy, HBV management, nucleoside analogue, pharmaceutical exporter India, antiviral tablet manufacturer India.

Entecashiv 0.5 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Molnulee Capsule
Composition: Molnupiravir 200mg
International Trade Name: Lagevrio®

Molnulee Capsule is a high-quality antiviral medication containing Molnupiravir 200mg, a generic equivalent of the internationally recognized Lagevrio®. Manufactured in WHO-GMP certified facilities, Molnulee is supplied by trusted pharmaceutical exporters from India to support global COVID-19 treatment programs.

Molnupiravir is a nucleoside analog that inhibits SARS-CoV-2 replication by inducing viral RNA mutagenesis. Molnulee 200mg Capsule is primarily indicated for the treatment of mild to moderate COVID-19 in adult patients at high risk of progressing to severe disease, helping to reduce hospitalization and disease severity.

Molnupiravir 200mg capsule, Molnulee capsule, Lagevrio generic, COVID-19 antiviral therapy, oral antiviral treatment, SARS-CoV-2 infection management, Indian pharmaceutical exporter, antiviral medication supplier India.

Molnulee Capsule is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government COVID-19 programs, and international pharmaceutical distributors.

Velpanat Tablets
Composition: Velpatasvir 100 mg + Sofosbuvir 400 mg
Manufacturer: Natco Pharma Ltd
International Trade Name: Epclusa®

Velpanat Tablets is a high-quality fixed-dose combination of Velpatasvir 100 mg and Sofosbuvir 400 mg, a trusted antiviral therapy equivalent to the internationally recognized brand Epclusa®. Manufactured in WHO-GMP certified facilities, Velpanat Tablets are supplied by reputable pharmaceutical exporters from India, supporting advanced global antiviral treatment programs, particularly for chronic hepatitis C virus (HCV) infection across all genotypes.

Velpatasvir is an NS5A inhibitor, and Sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase. Together, they effectively suppress viral replication, promoting sustained virologic response and reducing liver damage. Velpanat Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis C infection, including those with compensated liver disease, regardless of HCV genotype.

Keywords: Velpatasvir 100 mg + Sofosbuvir 400 mg tablet, Velpanat tablet, Epclusa biosimilar, chronic hepatitis C treatment, pan-genotypic antiviral therapy, HCV management, fixed-dose combination, pharmaceutical exporter India, antiviral tablet manufacturer India.

Velpanat Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Resof-L Tablet
Composition: Ledipasvir 90mg + Sofosbuvir 400mg
International Trade Name: Harvoni®

Resof-L Tablet is a high-quality fixed-dose combination of Ledipasvir and Sofosbuvir, a generic equivalent of the internationally recognized Harvoni®. Manufactured in WHO-GMP certified facilities, Resof-L is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis C virus (HCV) infection.

This combination includes Ledipasvir, an NS5A inhibitor, and Sofosbuvir, an NS5B nucleotide polymerase inhibitor. Together, they provide potent, once-daily suppression of HCV replication, enabling effective, interferon-free treatment of adult patients with chronic hepatitis C, including those with genotype 1 infection.

Ledipasvir + Sofosbuvir tablets, Resof-L tablets, Harvoni generic, HCV antiviral therapy, chronic hepatitis C management, direct-acting antiviral (DAA), Indian pharmaceutical exporter, hepatitis C treatment provider India.

Resof-L Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Harvoni Resof Tablets
Composition: Ledipasvir 90mg + Sofosbuvir 400mg
International Trade Name: Harvoni®

Harvoni Resof is a premium-quality combination of Ledipasvir 90mg and Sofosbuvir 400mg tablets, a highly effective therapy for chronic hepatitis C virus (HCV) infection. Manufactured in WHO-GMP certified facilities, Harvoni Resof is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for HCV genotype 1 infection.

Ledipasvir, an NS5A inhibitor, combined with Sofosbuvir, an NS5B nucleotide polymerase inhibitor, provides a potent, once-daily, oral antiviral regimen that targets multiple steps in the HCV replication cycle. Harvoni Resof is primarily indicated for the treatment of chronic hepatitis C in adult patients, including those with compensated liver disease, prior treatment experience, or co-infection with HIV.

Ledipasvir + Sofosbuvir 90mg/400mg tablets, Harvoni Resof tablets, Harvoni combination therapy, HCV antiviral treatment, chronic hepatitis C management, oral direct-acting antiviral (DAA), Indian pharmaceutical exporter, and hepatitis C therapy provider India.

Harvoni Resof is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Tavin 300mg Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Viread®

Tavin 300mg is a high-quality Tenofovir Disoproxil Fumarate 300mg tablet, a potent antiviral medication and generic equivalent of the internationally recognized Viread®. Manufactured in WHO-GMP certified facilities, Tavin is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection and HIV-1 management.

Tenofovir Disoproxil Fumarate (TDF) is a nucleotide reverse transcriptase inhibitor (NRTI) that effectively suppresses viral replication by inhibiting the reverse transcriptase enzyme, helping reduce viral load and prevent disease progression. Tavin 300mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients as well as for HIV-1 infection in combination with other antiretroviral agents.

Tenofovir Disoproxil Fumarate 300mg tablets, Tavin tablets, Viread generic, HBV antiviral therapy, HIV-1 antiretroviral therapy, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B and HIV treatment provider India.

Tavin 300mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government antiviral programs, and international pharmaceutical distributors.

• Trustiva Tablet
  Composition: Emtricitabine 200mg + Tenofovir Disoproxil Fumarate 300mg + Efavirenz 600mg
  International Trade Name: Atripla®

  Trustiva Tablet is a high-quality fixed-dose combination tablet of Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz, a generic equivalent of the internationally recognized Atripla®. Manufactured in WHO-GMP certified facilities, Trustiva is supplied by trusted pharmaceutical exporters from India to support advanced global antiretroviral treatment programs, particularly for HIV-1 infection.

  This combination tablet combines three potent antiretroviral agents: Emtricitabine (a nucleoside reverse transcriptase inhibitor), Tenofovir Disoproxil Fumarate (a nucleotide reverse transcriptase inhibitor), and Efavirenz (a non-nucleoside reverse transcriptase inhibitor). Together, they provide once-daily, highly effective suppression of HIV-1 viral replication, helping reduce viral load, improve immune function, and prevent disease progression.

  Emtricitabine + Tenofovir Disoproxil Fumarate + Efavirenz tablets, Trustiva tablets, Atripla generic, HIV-1 antiretroviral therapy, fixed-dose combination ARV, Indian pharmaceutical exporter, HIV treatment provider India.

   

  Trustiva Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government HIV programs, and international pharmaceutical distributors.

TAFNAT 25 mg Tablets
Composition: Tenofovir Alafenamide 25 mg
International Trade Name: Vemlidy®

TAFNAT 25 mg Tablets is a high-quality Tenofovir Alafenamide (TAF) 25 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Vemlidy®. Manufactured in WHO-GMP certified facilities, TAFNAT Tablets are supplied by reliable pharmaceutical exporters from India, supporting global treatment programs for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide is a nucleotide reverse transcriptase inhibitor (NtRTI) that selectively targets HBV replication in hepatocytes, providing effective viral suppression with improved safety and reduced impact on kidney function and bone mineral density compared to conventional Tenofovir formulations. TAFNAT 25 mg Tablets are primarily indicated for the treatment of adult patients with chronic hepatitis B infection.

Keywords: Tenofovir Alafenamide 25 mg tablet, TAFNAT tablet, Vemlidy biosimilar, chronic hepatitis B treatment, antiviral therapy, HBV management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

TAFNAT 25 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, outpatient clinics, government health programs, and international pharmaceutical distributors.

Tenohep AF 25mg Tablet
Composition: Tenofovir Alafenamide 25mg
International Trade Name: Vemlidy®

Tenohep AF 25mg is a high-quality Tenofovir Alafenamide 25mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Vemlidy®. Manufactured in WHO-GMP certified facilities, Tenohep AF is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide (TAF) is a novel prodrug of Tenofovir that effectively suppresses HBV replication at a lower dose, offering improved renal and bone safety compared to Tenofovir Disoproxil Fumarate (TDF). Tenohep AF 25mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with compensated liver disease.

Tenofovir Alafenamide 25mg tablets, Tenohep AF tablets, Vemlidy generic, HBV antiviral therapy, chronic hepatitis B management, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Tenohep AF 25mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Ricovir 300 mg Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Viread®

Ricovir 300 mg Tablets is a high-quality Tenofovir Disoproxil Fumarate (TDF) 300 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Viread®. Manufactured in WHO-GMP certified facilities, Ricovir Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV and chronic hepatitis B virus (HBV) treatment programs.

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI) that effectively suppresses viral replication in HIV-1 and HBV infections, helping maintain immune function and preventing disease progression. Ricovir 300 mg Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection and chronic hepatitis B infection.

Keywords: Tenofovir Disoproxil Fumarate 300 mg tablet, Ricovir tablet, Viread biosimilar, antiviral therapy, HIV treatment, chronic hepatitis B management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Ricovir 300 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Treavir 300mg Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Viread®

Treavir 300mg is a high-quality Tenofovir Disoproxil Fumarate 300mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Viread®. Manufactured in WHO-GMP certified facilities, Treavir is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection and HIV-1 management.

Tenofovir Disoproxil Fumarate (TDF) effectively inhibits viral replication by blocking the reverse transcriptase enzyme, reducing viral load, and preventing disease progression. Treavir 300mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients and as part of combination antiretroviral therapy for HIV-1 infection.

Tenofovir Disoproxil Fumarate 300mg tablets, Treavir tablets, Viread generic, HBV antiviral therapy, HIV-1 antiretroviral therapy, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B and HIV treatment provider India.

Treavir 300mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government antiviral programs, and international pharmaceutical distributors.

Tenolam Tablets
Composition: Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Combivir® / Truvada® (depending on regional reference)

Tenolam Tablets is a high-quality fixed-dose combination of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate 300 mg, a trusted antiviral therapy for HIV-1 and chronic hepatitis B virus (HBV) infections. Manufactured in WHO-GMP certified facilities, Tenolam Tablets are supplied by reputable pharmaceutical exporters from India, supporting global antiretroviral treatment programs with a convenient once-daily dosing regimen.

Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). Together, they effectively inhibit viral replication, help maintain immune function, and reduce disease progression. Tenolam Tablets are primarily indicated for adult and adolescent patients with HIV-1 infection and for the management of chronic hepatitis B infection.

Keywords: Lamivudine 300 mg + Tenofovir Disoproxil Fumarate 300 mg tablet, Tenolam tablet, fixed-dose combination, HIV treatment, chronic hepatitis B management, antiviral therapy, NRTI + NtRTI combination, pharmaceutical exporter India, antiretroviral manufacturer India.

Tenolam Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tenof EM Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg + Emtricitabine 200mg
International Trade Name: Truvada®

Tenof EM Tablet is a high-quality fixed-dose combination of Tenofovir Disoproxil Fumarate and Emtricitabine, a generic equivalent of the internationally recognized Truvada®. Manufactured in WHO-GMP certified facilities, Tenof EM is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for HIV-1 infection and pre-exposure prophylaxis (PrEP).

This combination includes Tenofovir Disoproxil Fumarate (TDF), a nucleotide reverse transcriptase inhibitor, and Emtricitabine (FTC), a nucleoside reverse transcriptase inhibitor. Together, they provide potent suppression of HIV-1 replication, reduce viral load, and help improve immune function in adult patients.

Tenofovir Disoproxil Fumarate + Emtricitabine tablets, Tenof EM tablets, Truvada generic, HIV-1 antiretroviral therapy, fixed-dose combination ARV, PrEP therapy, Indian pharmaceutical exporter, HIV treatment provider India.

Tenof EM Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government HIV programs, and international pharmaceutical distributors.

Ricovir EM Tablets
Composition: Emtricitabine 200 mg + Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Truvada®

Ricovir EM Tablets is a high-quality fixed-dose combination of Emtricitabine 200 mg and Tenofovir Disoproxil Fumarate 300 mg, a trusted antiretroviral therapy equivalent to the internationally recognized brand Truvada®. Manufactured in WHO-GMP certified facilities, Ricovir EM Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV treatment programs and pre-exposure prophylaxis (PrEP) initiatives.

Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). Together, they effectively suppress HIV-1 replication, maintain immune function, and reduce the risk of disease progression. Ricovir EM Tablets are primarily indicated for adult and adolescent patients with HIV-1 infection and for HIV pre-exposure prophylaxis (PrEP) in high-risk populations.

Keywords: Emtricitabine + Tenofovir Disoproxil Fumarate tablet, Ricovir EM tablet, Truvada biosimilar, fixed-dose combination, HIV treatment, HIV PrEP, antiretroviral therapy, NRTI + NtRTI combination, pharmaceutical exporter India, antiretroviral manufacturer India.

Ricovir EM Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tenvir EM Tablet
Composition: Emtricitabine 200mg + Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Truvada®

Tenvir EM Tablet is a high-quality fixed-dose combination of Emtricitabine and Tenofovir Disoproxil Fumarate, a generic equivalent of the internationally recognized Truvada®. Manufactured in WHO-GMP certified facilities, Tenvir EM is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for HIV-1 infection and pre-exposure prophylaxis (PrEP).

This combination includes Emtricitabine (a nucleoside reverse transcriptase inhibitor, NRTI) and Tenofovir Disoproxil Fumarate (a nucleotide reverse transcriptase inhibitor, NRTI), providing potent suppression of HIV-1 replication, reduction in viral load, and improved immune function in adult patients.

Emtricitabine + Tenofovir Disoproxil Fumarate tablets, Tenvir EM tablets, Truvada generic, HIV-1 antiretroviral therapy, fixed-dose combination ARV, PrEP therapy, Indian pharmaceutical exporter, HIV treatment provider India.

Tenvir EM Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government HIV programs, and international pharmaceutical distributors.

Taftrio Tablets
Composition: Bictegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg
International Trade Name: Biktarvy®

Taftrio Tablets is a high-quality fixed-dose combination of Bictegravir 50 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide 25 mg, a trusted antiretroviral therapy equivalent to the internationally recognized brand Biktarvy®. Manufactured in WHO-GMP certified facilities, Taftrio Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV treatment programs with a convenient once-daily dosing regimen.

Bictegravir is an integrase strand transfer inhibitor (INSTI), Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Alafenamide (TAF) is a nucleotide reverse transcriptase inhibitor (NtRTI). Together, they effectively suppress HIV-1 replication, maintain immune function, and reduce the risk of disease progression. Taftrio Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection.

Keywords: Bictegravir + Emtricitabine + Tenofovir Alafenamide tablet, Taftrio tablet, Biktarvy biosimilar, fixed-dose combination, HIV treatment, antiretroviral therapy, NRTI + NtRTI + INSTI combination, pharmaceutical exporter India, HIV medication manufacturer India.

Taftrio Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tafnat EM Tablets
Composition: Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg
International Trade Name: Descovy®

Tafnat EM Tablets is a high-quality fixed-dose combination of Emtricitabine 200 mg and Tenofovir Alafenamide (TAF) 25 mg, a trusted antiretroviral therapy equivalent to the internationally recognized brand Descovy®. Manufactured in WHO-GMP certified facilities, Tafnat EM Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV treatment programs and pre-exposure prophylaxis (PrEP) initiatives.

Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir Alafenamide (TAF) is a nucleotide reverse transcriptase inhibitor (NtRTI). Together, they effectively suppress HIV-1 replication, maintain immune function, and reduce the risk of disease progression. Tafnat EM Tablets are primarily indicated for adult and adolescent patients with HIV-1 infection and for HIV PrEP in high-risk populations.

Keywords: Emtricitabine + Tenofovir Alafenamide tablet, Tafnat EM tablet, Descovy biosimilar, fixed-dose combination, HIV treatment, HIV PrEP, antiretroviral therapy, NRTI + NtRTI combination, pharmaceutical exporter India, antiretroviral manufacturer India.

Tafnat EM Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tenof 300mg Tablet
Composition: Tenofovir Disoproxil Fumarate 300mg
International Trade Name: Viread®

Tenof 300mg is a high-quality Tenofovir Disoproxil Fumarate 300mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Viread®. Manufactured in WHO-GMP certified facilities, Tenof is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection and HIV-1 management.

Tenofovir Disoproxil Fumarate (TDF) effectively inhibits viral replication by blocking the reverse transcriptase enzyme, reducing viral load, and preventing disease progression. Tenof 300mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients and as part of combination antiretroviral therapy for HIV-1 infection.

Tenofovir Disoproxil Fumarate 300mg tablets, Tenof tablets, Viread generic, HBV antiviral therapy, HIV-1 antiretroviral therapy, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B and HIV treatment provider India.

Tenof 300mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government antiviral programs, and international pharmaceutical distributors.

Tenofoshiv 300 mg Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Viread®

Tenofoshiv 300 mg Tablets is a high-quality Tenofovir Disoproxil Fumarate (TDF) 300 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Viread®. Manufactured in WHO-GMP certified facilities, Tenofoshiv Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV and chronic hepatitis B virus (HBV) treatment programs.

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI) that effectively suppresses viral replication in HIV-1 and HBV infections, helping maintain immune function and preventing disease progression. Tenofoshiv 300 mg Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection and chronic hepatitis B infection.

Keywords: Tenofovir Disoproxil Fumarate 300 mg tablet, Tenofoshiv tablet, Viread biosimilar, antiviral therapy, HIV treatment, chronic hepatitis B management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Tenofoshiv 300 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.

Tenvir AF 25mg Tablet
Composition: Tenofovir Alafenamide 25mg
International Trade Name: Vemlidy®

Tenvir AF 25mg is a high-quality Tenofovir Alafenamide 25mg tablet, a potent nucleotide reverse transcriptase inhibitor (NRTI) and generic equivalent of the internationally recognized Vemlidy®. Manufactured in WHO-GMP certified facilities, Tenvir AF is supplied by trusted pharmaceutical exporters from India to support advanced global antiviral treatment programs, particularly for chronic hepatitis B virus (HBV) infection.

Tenofovir Alafenamide (TAF) is a novel prodrug of Tenofovir that provides effective suppression of HBV replication at a lower dose, offering improved renal and bone safety compared to Tenofovir Disoproxil Fumarate (TDF). Tenvir AF 25mg Tablet is primarily indicated for the treatment of chronic hepatitis B in adult patients, including those with compensated liver disease.

Tenofovir Alafenamide 25mg tablets, Tenvir AF tablets, Vemlidy generic, HBV antiviral therapy, chronic hepatitis B management, nucleotide analogue antiviral, Indian pharmaceutical exporter, hepatitis B treatment provider India.

Tenvir AF 25mg Tablet is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, specialty clinics, government hepatitis programs, and international pharmaceutical distributors.

Tenohep 300 mg Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Viread®

Tenohep 300 mg Tablets is a high-quality Tenofovir Disoproxil Fumarate (TDF) 300 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Viread®. Manufactured in WHO-GMP certified facilities, Tenohep Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV and chronic hepatitis B virus (HBV) treatment programs.

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI) that effectively suppresses viral replication in HIV-1 and HBV infections, helping maintain immune function and preventing disease progression. Tenohep 300 mg Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection and chronic hepatitis B infection.

Keywords: Tenofovir Disoproxil Fumarate 300 mg tablet, Tenohep tablet, Viread biosimilar, antiviral therapy, HIV treatment, chronic hepatitis B management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Tenohep 300 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.